—

NEA Management Company, LLC

Q1 2026 13F Holdings

  • Location
    timonium, MD
  • Num holdings

    26

  • Value ($000)

    $1,759,161

  • Date Filed
    05/15/2026
  • Form type
    13F-HR
  • CIK
    0001512848
  • All SEC filings
  • Note
    Holdings aggregated across “other managers” listed in original SEC filing, see here for detailed holdings broken out by other managers
Compare Q1 2026 to
Select Quarter
Issuer Name
Class
CUSIP
VALUE
%
Shares
Principal
Option Type
A
ACLX

Arcellx, Inc.

COMMON STOCK
03940C100
$349.66M
20 %

3,045,262

C
CELC

Celcuity Inc.

COM
15102K100
$260.87M
15 %

2,285,561

---

Spyglass Pharma, Inc.

COM SHS
85220G109
$191.53M
11 %

7,392,301

---

Trevi Therapeutics, Inc.

COM
89532M101
$157.74M
9 %

13,222,228

Y
YB4P

Savara, Inc.

COM
805111101
$133.61M
8 %

24,471,264

G
GLUE

Monte Rosa Therapeutics, Inc.

COM
61225M102
$126.54M
7 %

7,692,298

---

MBX Biosciences, Inc.

COM
55287L101
$107.89M
6 %

3,614,486

---

Zenas BioPharma, Inc.

COM
98937L105
$78.65M
5 %

4,023,219

C
COUR

Coursera, Inc.

COM
22266M104
$74.89M
4 %

12,867,769

A
AUPH

Aurinia Pharmaceuticals, Inc.

COM
05156V102
$58.83M
3 %

3,969,834

Rows Per Page
10
  • 10
  • 50
  • 100
1 - 10 of 26